The Cost-Effectiveness of Daclizumab Beta Vs Fingolimod for...

The Cost-Effectiveness of Daclizumab Beta Vs Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis Patients With Inadequate Response To Prior Treatment In Scotland

Tempest, M, Bougeard, C, Harrington, A, Xaplanteris, L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2017.08.1950
Date:
October, 2017
File:
PDF, 78 KB
english, 2017
Conversion to is in progress
Conversion to is failed